Arcutis’ Zoryve Shows Progress for Individuals with Atopic, Seborrheic Dermatitis

Estimated read time 1 min read

Company displayed findings at the 2024 Winter Clinical Dermatology Conference in Hawaii demonstrating significant improvements in atopic dermatitis and seborrheic dermatitis.

You May Also Like

More From Author

+ There are no comments

Add yours